This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
Barrett Esophagus, Esophageal Adenocarcinoma
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
-
Mayo Clinic Arizona, Scottsdale, Arizona, United States, 85259
Mayo Clinic Jacksonville, Jacksonville, Florida, United States, 32224
Mayo Clinic Health Systems - Austin, Austin, Minnesota, United States, 55912
Mayo Clinic Health Systems - Mankato, Mankato, Minnesota, United States, 56001
Mayo Clinic Rochester, Rochester, Minnesota, United States, 55905
Northwell Health, New Hyde Park, New York, United States, 11040
Baylor Scott & White Research Institute, Dallas, Texas, United States, 75246
Mayo Clinic Health System-Eau Claire, Eau Claire, Wisconsin, United States, 54701
Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, United States, 54601
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 90 Years
ALL
Yes
Mayo Clinic,
Prasad G. Iyer, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic
2027-01-02